TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
Xi Chen(Baylor College of Medicine), Jennifer A. Pietenpol(Vanderbilt University), Joshua A. Bauer(Vanderbilt University), Jiang Li(Jiangsu University), W.H. Gray(Vanderbilt University), Brian D. Lehmann(Vanderbilt University), Yu Shyr(Vanderbilt University)
Cited by 303
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
|Cancer Cell|2004|1.1k
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|572
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
|Cancer Immunology Research|2016|493